Please assess the completion status of the following clinical trial:

Trial Title: Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Records of men aged \>18 years with an index PDE5 inhibitor (sildenafil, tadalafil or vardenafil) prescription between January 1st, 1999, and June 30th, 2008~* no prior PDE5 inhibitor prescription before the index prescription~* continuous enrolment with medical history for ≥60 months prior to the index prescription date~Exclusion Criteria:~* Records of female subjects and any male subjects not meeting the inclusion criteria will be excluded~* A subject can only be selected once independent of the assignment to the target or the control populations.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PDE5 inhibitor prescription (Type: None): None
- Age-matched Control (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).